To our knowledge, this study is the first to assess the effect of time of ezetimibe/simvastatin administration on the serum cholesterol level. The results show that morning administration of ezetimibe ...

New research suggests that pairing a moderate-intensity statin with ezetimibe can match the cardiovascular benefits of high-intensity statins while reducing the likelihood of developing type 2 ...

Please provide your email address to receive an email when new articles are posted on . Obicetrapib plus ezetimibe lowered LDL nearly 50% vs. placebo in patients with high atherosclerotic risk.

Please provide your email address to receive an email when new articles are posted on . A combination of obicetrapib and ezetimibe further lowered LDL in statin-treated patients with dyslipidemia. A ...

Results from the largest community-based clinical trial to date, involving more than 3000 patients, has shown that adding the cholesterol absorption inhibitor ezetimibe to ongoing stable statin ...

A Swedish database of over 35,000 individuals found better cardiovascular outcomes when ezetimibe was added earlier to statin therapy for secondary prevention. Study authors deemed ezetimibe a ...

Obicetrapib, a Lazarus-like cholesteryl ester transfer protein (CETP) inhibitor currently on its second life, checked another box in its development program with investigators showing the drug could ...